Transplant outcomes
| Variable | Patient no. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
| Transplantation | |||||||||
| Age at transplantation (yr) | 33 | 13 | 10 | 26 | 20 | 51 | 11 | 10 | 30 |
| Donor type | LD | LD | LD | DD | LD | DD | LD | LD | LD |
| Donor age (yr) | 60 | 41 | 42 | 16 | 49 | 65 | 38 | 42 | 57 |
| HLA mismatch | 3 | 3 | 2 | 0 | 1 | 5 | 3 | 2 | 3 |
| Immunosuppression | CsA, Pd, (+MMF) | CsA, Pd, (–AZA) | TAC, Pd, MMF | TAC, Pd, MMF | TAC, Pd, MMF | TAC, Pd, MMF | TAC, Pd, MMF | TAC, Pd, MMF | TAC, Pd, MMF |
| Outcome | |||||||||
| Follow-up (mo) | 341 | 259 | 185 | 175 | 148 | 148 | 126 | 49 | 2 |
| Serum creatinine (mg/dL) | 5.64 | 0.78 | 6.78 | 0.72 | 0.95 | 1.38 | 1.36 | 5.39 | 1.06 |
| Acute rejection | No | No | No | No | No | Yes | No | Yes | No |
| Admission for febrile UTI | 3 | 3 | 3 | 4 | 0 | 0 | 0 | 5 | 0 |
| Pathogens (>105 CFU in urine) | None | None | None | None | |||||
| Graft failure | Yes | No | Yes | No | No | No | No | Yes | No |
| Graft survival time (mo) | 302 | 259 | 107 | 175 | 148 | 148 | 126 | 35 | 2 |
Borderline change on protocol biopsy without renal dysfunction.
LD, living donor; DD, deceased donor; HLA, human leukocyte antigen; CsA, cyclosporine A; Pd, prednisolone; MMF, mycophenolate mofetil; AZA, azathioprine; TAC, tacrolimus; UTI, urinary tract infection; CFU, colony-forming unit.